Jazz (JAZZ) Begins Zepzelca Combo Study for First-Line SCLC
Published on December 1, 2021
Jazz Pharmaceuticals (JAZZ) and partner Roche enrol the first patient in the phase III study to investigate the novel combination of Zepzelca and Tecentriq for small cell lung cancer.